XML 54 R38.htm IDEA: XBRL DOCUMENT
v3.21.1

Supplemental Cash Flow Information (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2020
Supplemental Cash Flow Information [Abstract] |
Schedule of Supplemental Cash Flow Information | Supplemental cash flow information for the years ended December 31:
|  | 2020 |  |  | 2019 |
Cash paid for interest |  | $ | 185,000 |  |  | $ | 128,000 |
Non-cash investing and financing activities: |  |  |  |  |  |  |  |
Impact of adoption of lease accounting standards |  | $ | - |  |  | $ | 1,616,000 |
Gain from change in fair value of interest rate swap derivatives |  | $ | - |  |  | $ | 7,000 |
Common stock issued upon conversion of convertible note |  | $ | - |  |  | $ | 500,000 |
Equity issued to purchase intangible assets |  | $ | - |  |  | $ | 145,000 |
Common A Shares issued for prepaid marketing services |  | $ | 210,000 |  |  | $ | - |
Common A Shares issued for Impact BioMedical |  | $ | 3,132,000 |  |  | $ | - |
Non-controlling interest related to Impact BioMedical |  | $ | 3,910,000 |  |  | $ | - |
Series A Preferred Shares issued for Impact BioMedical |  | $ | 35,187,000 |  |  | $ | - |
Notes receivable settled for assets in lieu of cash |  | $ | 838,000 |  |  | $ | - |

X
- Definition Tabular disclosure of supplemental cash flow information for the periods presented. + References No definition available. + Details
Name: | us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SupplementalCashFlowInformationAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration